Cite
Supplementary Figure 2 from Dual mTORC1/2 Blockade Inhibits Glioblastoma Brain Tumor Initiating Cells In Vitro and In Vivo and Synergizes with Temozolomide to Increase Orthotopic Xenograft Survival
MLA
Samuel Weiss, et al. Supplementary Figure 2 from Dual MTORC1/2 Blockade Inhibits Glioblastoma Brain Tumor Initiating Cells In Vitro and In Vivo and Synergizes with Temozolomide to Increase Orthotopic Xenograft Survival. Mar. 2023. EBSCOhost, https://doi.org/10.1158/1078-0432.22456958.
APA
Samuel Weiss, J. Gregory Cairncross, Xueqing Q. Lun, Stephanie A. Nguyen, Owen D.M. Stechishin, & H. Artee Luchman. (2023). Supplementary Figure 2 from Dual mTORC1/2 Blockade Inhibits Glioblastoma Brain Tumor Initiating Cells In Vitro and In Vivo and Synergizes with Temozolomide to Increase Orthotopic Xenograft Survival. https://doi.org/10.1158/1078-0432.22456958
Chicago
Samuel Weiss, J. Gregory Cairncross, Xueqing Q. Lun, Stephanie A. Nguyen, Owen D.M. Stechishin, and H. Artee Luchman. 2023. “Supplementary Figure 2 from Dual MTORC1/2 Blockade Inhibits Glioblastoma Brain Tumor Initiating Cells In Vitro and In Vivo and Synergizes with Temozolomide to Increase Orthotopic Xenograft Survival,” March. doi:10.1158/1078-0432.22456958.